| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |
| 06/30/1992 | CA1304375C Benzylaminoaryl-dihydropyridinelactones, process for their preparation, and their use in medicaments |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010468A1 Anti-atherosclerotic aryl compounds |
| 06/25/1992 | WO1992010183A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
| 06/25/1992 | WO1992010182A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 06/25/1992 | WO1992010097A1 Angiotensin ii receptor blocking compositions |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/24/1992 | EP0491525A1 Benzamide and sulfonamide hypoglycemic agents |
| 06/24/1992 | EP0491361A2 Short peptides having the effect of insulin |
| 06/24/1992 | EP0491226A1 Substituted pyridyl-dihydroxyheptenoic acid and its salts |
| 06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124360 Administering D-chiroinositol to achieve reduction in blood glucose level |
| 06/23/1992 | US5124357 Containing lysine; increases weight gain and feed utilization |
| 06/23/1992 | US5124337 Treating atherosclerosis |
| 06/23/1992 | US5124335 Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124314 Treatment of diabetes or hypoglycemia |
| 06/23/1992 | CA1303996C Methods for treatment of sundamaged human skin with retinoids |
| 06/21/1992 | WO1992011268A1 Novel methylenebisphosphonic acid derivatives |
| 06/21/1992 | WO1992011019A1 Psyllium and cholestyramine compositions with improved palatability |
| 06/21/1992 | WO1992011007A1 Alteration of rate and character of hair growth |
| 06/21/1992 | CA2098734A1 Novel mrthylenebisphosphonic acid derivatives |
| 06/21/1992 | CA2058068A1 1,3-dioxolane derivatives as cholesterol-lowering agents |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/19/1992 | CA2057324A1 Benzamide and sulfonamide hypoglycemic agents |
| 06/17/1992 | EP0490818A1 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof |
| 06/17/1992 | EP0490772A1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them |
| 06/17/1992 | EP0490561A2 Nutrition |
| 06/17/1992 | EP0356454B1 Cyclic hydrocarbons with an aminoalkyl sidechain |
| 06/17/1992 | DE4040026A1 New substd. pyridyl di:hydroxy heptenoic acid derivs. |
| 06/16/1992 | US5122603 Purified insulin mediators and purification process for same |
| 06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
| 06/16/1992 | US5122542 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes |
| 06/16/1992 | US5122534 Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| 06/16/1992 | US5122513 Fish growth using bovine placental lactogen |
| 06/16/1992 | US5122512 Swine growth promoting composition |
| 06/16/1992 | CA2057651A1 Agistatins, novel metabolites from fusarium sp., a process for their preparation, and their use |
| 06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
| 06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
| 06/13/1992 | WO1992010168A1 Directly compressible xylitol and method |
| 06/11/1992 | WO1992009561A1 New amide derivatives |
| 06/11/1992 | WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 06/10/1992 | EP0489663A1 Thiazolidine-2,4-dione compound, method for production thereof, and medicine containing the compound for cure diabetic complications |
| 06/10/1992 | EP0489423A1 Bile-acid derivatives, a process for their preparation and their use as medicines |
| 06/10/1992 | EP0489308A1 Partricin derivatives |
| 06/10/1992 | EP0489102A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/09/1992 | US5120848 Imidazole derivatives |
| 06/09/1992 | US5120782 Substituted pyrrolo-pyridines pharmaceuticals |
| 06/09/1992 | US5120766 Anticholesterol, antilipemic agent |
| 06/09/1992 | US5120764 Administering penicillamine and allenylamines to inhibit crosslinking of collagen |
| 06/09/1992 | US5120760 Administering gamma-linolenic acid and stearidonic acid |
| 06/09/1992 | US5120729 Beta-lactams as antihypercholesterolemics |
| 06/09/1992 | US5120713 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 06/09/1992 | CA1303045C Selective inhibitors for benzylaminoxidases with respect to other aminoxidases |
| 06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
| 06/09/1992 | CA1303025C 17-.beta. A-OH 19-NORSTEROIDS SUBSTITUTED IN 17A, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 06/09/1992 | CA1302927C Efomycin g, its preparation and its use as a yield promoter in animals |
| 06/09/1992 | CA1302889C Pharmaceutical composition containing 4-(2-naphthylmethoxy) piperidine |
| 06/09/1992 | CA1302878C Agent for the regulation of the appetite or a sleeping agent |
| 06/08/1992 | CA2056967A1 Use of organic compounds |
| 06/08/1992 | CA2056957A1 Nutrition |
| 06/03/1992 | EP0488928A2 Pharmaceutical formulations containing a mixture of higher primary aliphatic alcohols in the treatment of hypercholesterolaemia and hyperlypoproteinaemia type II and stimulation of sexual behavior in animals and humans |
| 06/03/1992 | EP0488897A1 New guanidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/03/1992 | EP0488800A2 Corandomized fat compositions for infant formulas |
| 06/03/1992 | EP0488513A2 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. |
| 06/03/1992 | EP0488059A2 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0484446A4 Carnitine supplemented finishing pig diet |
| 06/02/1992 | US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases |
| 06/02/1992 | US5118714 Aqueous extract from pittosporaceae effective for treating diabetes and liver dysfunction |
| 06/02/1992 | US5118687 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 06/02/1992 | US5118510 Niacin drink mix formulation |
| 06/02/1992 | CA1302425C Prodrugs of antihypercholesterolemic compounds |
| 06/02/1992 | CA1302406C Method of manufacturing moranoline derivatives |
| 05/31/1992 | CA2056657A1 Pharmaceutical formulations containing a mixture of higher primary aliphatic alcohols in the treatment of hypercholesterolaemia and hyperlypoproteinaemia type ii and stimulation of sexual behaviour in animals and humans |
| 05/30/1992 | CA2056560A1 Guanidine derivates, the process for the preparation thereof and the pharmaceutical compositions containing them |
| 05/29/1992 | WO1992009582A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008694A1 Aminosulfonyl urea acat inhibitors |
| 05/29/1992 | WO1992008693A1 Aminosulfonyl carbamates |
| 05/29/1992 | WO1992008692A1 Oxysulfonyl urea acat inhibitors |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/29/1992 | CA2094807A1 Aminosulfonyl carbamates |
| 05/29/1992 | CA2074729A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| 05/27/1992 | EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them |
| 05/27/1992 | CN1016784B Process for preparating homodisaccharide hypoglycemic agents |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | US5116851 Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides |
| 05/26/1992 | US5116848 N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| 05/26/1992 | US5116828 Pharmaceutical composition for treatment of osteoporosis |
| 05/26/1992 | US5116573 Labelled vitamin d3 derivative and production process thereof |
| 05/26/1992 | US5116494 Artificial pancreatic perfusion device with temperature sensitive matrix |
| 05/25/1992 | WO1992009281A2 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
| 05/25/1992 | CA2096853A1 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
| 05/24/1992 | CA2056008A1 Benzoselenazolinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 05/20/1992 | EP0486425A2 High acid system nutritional formulations |